Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duac Combination Gel for Facial Acne in Japanese Subjects
2017-001575-23Phase 4
- Sponsor
- GSK
- Start
- Sep 2017
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of clindamycin phosphate + benzoyl peroxide in acne vulgaris (2 arms), sponsored by GSK. Primary endpoint: Percent change in total lesion counts from baseline to Week 2.
02
Drugs
clindamycin phosphate + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2017-001575-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001575-23.